Imrecoxib
Catalog No. A18027
Imrecoxib (BAP-909) is a novel and selective cyclooxygenase 2 (COX-2) inhibitor with an IC50 value of 18 nM, it also inhibits COX1- activity with an IC50 value of 115 nM. Imrecoxib (BAP-909) has anti-inflammatory effect.
Catalog Num | A18027 |
---|---|
M. Wt | 369.48 |
Formula | C21H23NO3S |
Purity | >98% |
Storage | at -20°C 3 years Powder |
CAS No. | 395683-14-4 |
Synonyms | BAP-909; BAP 909; BAP909; Imrecoxib |
SMILES | O=C1N(CCC)CC(C2=CC=C(S(=O)(C)=O)C=C2)=C1C3=CC=C(C)C=C3 |
Imrecoxib (BAP-909) is a novel and selective cyclooxygenase 2 (COX-2) inhibitor with an IC50 value of 18 nM, it also inhibits COX1- activity with an IC50 value of 115 nM. Imrecoxib (BAP-909) has anti-inflammatory effect.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 27.07 mL | 135.33 mL | 270.65 mL |
0.5 mM | 5.41 mL | 27.07 mL | 54.13 mL |
1 mM | 2.71 mL | 13.53 mL | 27.07 mL |
5 mM | 0.54 mL | 2.71 mL | 5.41 mL |
*The above data is based on the productmolecular weight 369.48. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.